Diffusion Pharmaceuticals Inc (DFFN)


Stock Price Forecast

Sept. 11, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Diffusion Pharmaceuticals Inc chart...

About the Company

Diffusion Pharmaceuticals Inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body's ability to deliver oxygen to areas where it is needed most. Diffusion's lead product candidate, TSC, is being developed to enhance the diffusion of oxygen to tissues with low oxygen levels, also known as hypoxia, a serious complication of many of medicine's most intractable and difficult-to-treat conditions. In addition to TSC, Diffusion's product candidate DFN-529, a novel, allosteric PI3K/Akt/mTOR Pathway inhibitor, is in early-stage development.

Employees

14

Exchange

NASDAQ

Website

www.diffusionpharma.com

$0M

Total Revenue

14

Employees

$14M

Market Capitalization

-0.59

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $DFFN News

Diffusion Pharmaceuticals Announces Validation of European Patent for Oral Formulations of TSC

1mon ago, source: ADVFN

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) (“Diffusion” or “the Company”), a clinical-stage biotechnology company focused on extending the life expectancy of cancer patients, today ...

WATT, RETO and MIRO among mid-day movers

7mon ago, source: Hosted on MSN

Diffusion Pharmaceuticals (DFFN) +30%. Aurora Acquisition Corp. (AURC) +20%. ReTo Eco-Solutions (RETO) +21%. Now read: Chicken Soup: Notes Vs. Preferreds - Evaluating The Better Income Choice ...

Isaac Blech's Net Worth

1mon ago, source: Benzinga.com

Isaac Blech has an estimated net worth of $1.93 Billion. This is based on reported shares across multiple companies, which include Marina Biotech, Inc., GreenHouse Holdings, Inc., InspireMD, Inc ...

Questcor Pharmaceuticals,

6d ago, source: Forbes

Questcor Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.

Alnylam Pharmaceuticals

1d ago, source: Forbes

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Ionis Pharmaceuticals Inc IONS

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Amylyx Pharmaceuticals Inc AMLX

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Recursion Pharmaceuticals, Inc. (RXRX)

1mon ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

SNOA Sonoma Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the ...

CYCC Cyclacel Pharmaceuticals, Inc.

3d ago, source: Seeking Alpha

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company’s lead product includes ...

Elite Pharmaceuticals, Inc. (ELTP)

1y ago, source: Yahoo Finance

Elite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcript February 15, 2024 Elite Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...